Rotavirus vaccine bovine reassortant (sanofi pasteur)

N/A

Report date: 2022/07/04 19:38:02

Base Information

Drug NameRotavirus vaccine bovine reassortant (sanofi pasteur)
Drug Alias NameBRV-TVBRV vaccine - Shantha BiotechnicsLive attenuated tetravalent (G1-G4) bovine-human reassortant rotavirus vaccine - Shantha Biotechnics
ClassificationVaccines > Biological material > Viral vaccineVaccines > Application > Prophylactic vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsGastroenteritisRotavirus Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryIndia
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesShantha Biotechnics LtdSanofi Pasteur
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesShantha Biotechnics Ltd
Active IndicationsN/A
Inactive IndicationsGastroenteritisRotavirus Infections

Other Information

ATC CodeN/A
Related LinksWikipedia